Transformation, acceptance range [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2019-03-02 15:09 (639 d 12:47 ago) – Posting: # 19984
Views: 3,615

Hi John,

» » Was the study performed for Health Canada? In the 1989 draft 80–120% (untransformed data) were recommended and changed to 80–125% (log-transformed) in 1991.
»
» But your suggestion about Canada using non-transformed make sense(?) Can you tell me (or pt to me) about the Canadian guidance 89?

Another goody: At the “International Open Conference on Dissolution, Bioavailability, Bioequivalence” (Toronto, June 15–17, 1992) the current draft was provided (without a date), which stated

95% CI of relative mean AUC 80%–125%.

John Ruedy (Chairman, Expert Advisory Committee of Biovailability, HC’s HPB) pointed out in his presentation that the final guidance will require a 90% CI.
Couldn’t find the pre-1992 guidance so far. :-( Maybe my memory mixed the transformation-business up with this story (see the end of this post).

Dif-tor heh smusma 🖖
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
21,224 posts in 4,427 threads, 1,481 registered users;
online 7 (0 registered, 7 guests [including 6 identified bots]).
Forum time: Tuesday 03:56 CET (Europe/Vienna)

The fundamental cause of trouble in the world today is
that the stupid are cocksure
while the intelligent are full of doubt.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5